Eden Research Plc offers sustainable solutions for crop protection, animal health and consumer products in the United Kingdom and rest of Europe. The company is headquartered in Oxford, Oxfordshire and currently employs 23 full-time employees. The company went IPO on 2012-05-11. The firm develops and supplies biopesticide products and natural microencapsulation technologies to the global crop protection, animal health and consumer products industries. Its products include crop protection, animal health, and consumer products. Its crop protection includes Mevalone and Cedroz. Mevalone is a foliar, contact biofungicide which delivers a controlled release pattern of multiple terpene active ingredients. Cedroz is a terpene-based product developed in conjunction with Eastman Chemical Company as a post-planting solution to the problem of root-knot nematodes. The firm's Sustaine encapsulation technology is used to harness the biocidal activity of naturally occurring molecules produced by plants (terpenes) as part of their defence systems. Sustaine is used in a wide range of applications such as agricultural, animal health and consumer products
Follow-Up Questions
¿Quién es el CEO de Eden Research PLC?
Mr. Sean Smith es el Chief Executive Officer de Eden Research PLC, se unió a la empresa desde 2014.
¿Qué tal es el rendimiento del precio de la acción EDNSF?
El precio actual de EDNSF es de $0, ha decreased un 0% en el último día de negociación.
¿Cuáles son los temas de negocio principales o las industrias de Eden Research PLC?
Eden Research PLC pertenece a la industria Chemicals y el sector es Materials
¿Cuál es la capitalización bursátil de Eden Research PLC?
La capitalización bursátil actual de Eden Research PLC es $0
¿Es Eden Research PLC una compra, una venta o una posición de mantener?
Según los analistas de Wall Street, 3 analistas han realizado calificaciones de análisis para Eden Research PLC, incluyendo 2 fuerte compra, 2 compra, 1 mantener, 0 venta, y 2 fuerte venta
